CD19 and multiple sclerosis: Figure 2B shows the individual observed and predicted CD19+ vs. time profiles for four representative patients taking into account four different pathologies (i.e., neuromyelitis optica, Myasthenia gravis, multiple sclerosis and systemic lupus erythematosus).